Jco Oncology Practice
Overview
JCO Oncology Practice is a reputable peer-reviewed journal that focuses on providing practical and evidence-based information to healthcare professionals involved in the care of cancer patients. It covers a wide range of topics including clinical practice, research updates, treatment guidelines, and quality improvement strategies, making it an essential resource for oncologists and other specialists in the field.
Details
Details
Abbr.
JCO Oncol Pract
Start
2019
End
Continuing
Frequency
Monthly
p-ISSN
2688-1527
e-ISSN
2688-1535
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 4506
78
SJR / Ranks: 1750
1601
CiteScore / Ranks: 5214
4.90
JIF / Ranks: 2264
4.0
Recent Articles
1.
Caston N, Deng L, Williams C, Levitan E, Azuero A, Griffin R, et al.
JCO Oncol Pract
. 2025 Mar;
:OP2400736.
PMID: 40080789
Purpose: Over the course of the COVID-19 pandemic, the Food and Drug Administration allowed cancer clinical trials to make modifications. As policymakers consider sustaining these modifications, understanding patient perspectives on...
2.
Pandav K, Almahfouz Nasser S, Kimball K, Higgins K, Madabhushi A
JCO Oncol Pract
. 2025 Mar;
:OP2400797.
PMID: 40080779
Much work has been published on artificial intelligence (AI) and oncology, with many focusing on an algorithm perspective. However, very few perspective articles have explicitly discussed the role of AI...
3.
4.
Pottinger D, Niranjan S, Jahan N, Desai A
JCO Oncol Pract
. 2025 Mar;
:OP2400468.
PMID: 40080776
Purpose: Minority representation in cancer-related clinical trials (CCTs) is often inadequate. This poses a threat to the generalizability of studies and risks promoting health inequities. This scoping review set out...
5.
Banegas M, Nightingale C, Dressler E, Cooley M, Kamen C, Wagner L, et al.
JCO Oncol Pract
. 2025 Mar;
:OP2400902.
PMID: 40080774
Purpose: Health-related social needs (HRSNs) are associated with adverse cancer health outcomes. We assessed the processes for screening and responding to both HRSNs and financial distress and described the methods...
6.
7.
Sakanaka K, Fujii K, Kokubo M, Ogura M, Itasaka S, Sakamoto T, et al.
JCO Oncol Pract
. 2025 Mar;
:OP2400429.
PMID: 40080769
Purpose: This multi-institutional prospective cohort trial aimed to demonstrate the changes in physician-evaluated dysphagia and patient-reported outcomes (PROs) after palliative external beam radiotherapy (EBRT) in patients with incurable esophageal cancer...
8.
Goncalves M, Janowitz T
JCO Oncol Pract
. 2025 Mar;
:OP2500108.
PMID: 40080745
No abstract available.
9.
10.
Wang Y, Fleming F, Loh K
JCO Oncol Pract
. 2025 Mar;
:OP2500032.
PMID: 40053903
No abstract available.